Yahoo · Feb 2, 2026
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Smart Beta ETF report for IBD
NASDAQ · IBD
Inspire Corporate Bond Impact ESG ETF
Financial Services · Asset Management - Bonds
$23.29
Up+$0.06 (+0.26%)
Updated Sep 17, 2026, 10:21 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 450.75M
- P/E ratio
- —
- Dividend yield
- 4.32%
- 52-week range
- $22.94 – $24.78
- Volume
- 72.35K
- Avg. volume
- 60.58K
Price performance
IBD price history
1M range · 20 trading sessions · Daily adjusted prices
IBD closed at $23.29 after 20 trading sessions, down 1.61% for the selected period.
- Last close
- $23.29
- Period change
- -1.61%
- Period low
- $23.29
- Period high
- $23.69
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $23.33 | $23.6428 | $23.2601 | $23.29 | 72.35K |
| Sep 15, 2026 | $23.36 | $23.38 | $23.215 | $23.38 | 74.45K |
| Sep 14, 2026 | $23.305 | $23.37 | $23.28 | $23.37 | 54.84K |
| Sep 11, 2026 | $23.35 | $23.44 | $23.155 | $23.35 | 47.44K |
| Sep 10, 2026 | $23.42 | $23.6309 | $23.165 | $23.33 | 40.27K |
| Sep 9, 2026 | $23.55 | $23.60 | $23.4145 | $23.52 | 82.25K |
| Sep 8, 2026 | $23.54 | $23.56 | $23.45 | $23.45 | 159.33K |
| Sep 4, 2026 | $23.54 | $23.54 | $23.4552 | $23.505 | 50.78K |
| Sep 3, 2026 | $23.52 | $23.53 | $23.47 | $23.53 | 126.47K |
| Sep 2, 2026 | $23.48 | $23.4999 | $23.4443 | $23.48 | 76.23K |
| Sep 1, 2026 | $23.50 | $23.5187 | $23.40 | $23.51 | 68.39K |
| Aug 31, 2026 | $23.67 | $23.67 | $23.46 | $23.53 | 126.21K |
| Aug 28, 2026 | $23.69 | $23.69 | $23.51 | $23.55 | 85.61K |
| Aug 27, 2026 | $23.63 | $23.70 | $23.5397 | $23.62 | 70.27K |
| Aug 26, 2026 | $23.69 | $23.69 | $23.585 | $23.6384 | 76.91K |
| Aug 25, 2026 | $23.59 | $23.72 | $23.59 | $23.69 | 76.13K |
| Aug 24, 2026 | $23.58 | $23.6893 | $23.58 | $23.64 | 42.42K |
| Aug 21, 2026 | $23.67 | $23.71 | $23.5952 | $23.64 | 87.51K |
| Aug 20, 2026 | $23.65 | $23.6966 | $23.63 | $23.66 | 56.9K |
| Aug 19, 2026 | $23.75 | $23.759 | $23.6503 | $23.67 | 108.98K |
Latest IBD news
The latest Smart Investors Daily articles mentioning IBD.
Stock researchCompany · Overview
IBD research
Overview
Company profile and research snapshot.
Company profile
The fund generally invests at least 80% of its total assets in the component securities of the index. The index provider selects domestic corporate bonds issued by companies that have market capitalizations of $5 billion or more, have credit ratings of BBB- or higher from Standard and Poor’s or Baa3 or higher from Moody’s and which have an Inspire Impact Score® of zero or higher.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Jan 26, 2026
4 Key Market Signals To Watch
Investors could get nervous with each jolt of turbulence, whether geopolitical, political, or monetary. Or they could put the noise-cancelling headphones on and focus on the destination.
SeekingAlpha · Jan 26, 2026
The Bond Markets
US blue-chip companiesâ borrowing costs relative to Treasuries have fallen. The cost of borrowing for IG companies stands at 0.73 percentage points above the equivalent on US government debt
zacks.com · Dec 3, 2025
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
